Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial

INTRODUCTION.  GeneXpert® MTB/RIF (Xpert) is now widely distributed in high human immunodeficiency virus (HIV)/tuberculosis (TB)-burden countries. Yet, whether the test improves patient-important outcomes within HIV treatment programs in limited resource settings is unknown. METHODS.  To investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mupfumi, L., Makamure, B., Chirehwa, M., Sagonda, T., Zinyowera, S., Mason, P., Metcalfe, J. Z., Mutetwa, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324195/
https://www.ncbi.nlm.nih.gov/pubmed/25734106
http://dx.doi.org/10.1093/ofid/ofu038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324195/
https://www.ncbi.nlm.nih.gov/pubmed/25734106
http://dx.doi.org/10.1093/ofid/ofu038

Ejemplares similares